• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EMD 2.86% 3.6¢

EMYRIA LIMITED

Emyria Limited is an Australia-based early-stage drug development company. The Company is... Emyria Limited is an Australia-based early-stage drug development company. The Company is focused on delivering and developing treatments for mental health and select neurological conditions, guided by real-world data collected with patients across its wholly owned clinical service subsidiaries. Its pipeline comprises medication-assisted treatment programs and biopharmaceuticals, specifically methylenedioxy-methylamphetamine (MDMA) analogues and Ultra-Pure cannabidiol (CBD) capsules. Its Emyria Healthcare provides evidence-based treatment for patients not finding relief from conventional care, while also helping evaluate emerging new therapies like MDMA-assisted therapy for PTSD. Its Emyria Data is a robust and ethically sourced real-world data gathered with patients and used to improve its therapy and drug development programs. Its Emyria’s Pipeline includes new psychedelic-assisted therapies and drug treatments for mental health and select neurological diseases.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
EMD
general talk
5 6 7
15/02/25 382 145K
15/02/25 Last post  rasberry Comments Created with Sketch.  382  Views Created with Sketch.  145K 
EMD 14/02/25 0 148
14/02/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  148 
EMD 14/02/25 0 113
TRENDING NEWS
NEWS
15 Feb 2025
14/02/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  113 
EMD 05/02/25 7 2.0K
05/02/25 Last post  rasberry Comments Created with Sketch.  7  Views Created with Sketch.  2.0K 
EMD 04/02/25 0 284
04/02/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  284 
EMD 31/01/25 1 518
31/01/25 Last post  rasberry Comments Created with Sketch.  1  Views Created with Sketch.  518 
EMD 28/01/25 15 3.7K
28/01/25 Last post  rasberry Comments Created with Sketch.  15  Views Created with Sketch.  3.7K 
EMD
Emyria Research Report
21/01/25 20 7.0K
21/01/25 Last post  rasberry Comments Created with Sketch.  20  Views Created with Sketch.  7.0K 

See All Discussions arrow Created with Sketch.

Timeline

Letter to Shareholders - Notice of General Meeting
14 Feb 14:13
 
Notice of General Meeting/Proxy Form
14 Feb 14:13
 
Euroz Hartleys 2025 Healthcare Forum Presentation
04 Feb 09:31
 
Emyria Reports Promising 3-Month PTSD Treatment Results
04 Feb 09:25
 
December 2024 Quarterly Activities Report and Appendix 4C
31 Jan 12:15
 
Leadership Updates
22 Jan 09:20
 
View More arrow Created with Sketch.
(20min delay)
Last
3.6¢
Change
0.001(2.86%)
Mkt cap ! $16.58M
Open High Low Value Volume
3.6¢ 3.7¢ 3.6¢ $7.025K 195K

Buyers (Bids)

No. Vol. Price($)
1 159979 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
3.8¢ 6020 1
View Market Depth
Last trade - 16.10pm 14/02/2025 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.